NEUROCARE Project specifically focuses on
- Carbon-biointerface development offering reduced biofouling over the state-of-the-art, as set by the DREAMS project and improved biocompatibility.
- Interfacing of rigid MEAs and FETs with cells and organs to improve bidirectional communication with neurons for in vitro research and pharmacological applications.
- Nanoscale surface engineering and flexible macroscale implant materials for optimal contact to biological tissue.
- Making and testing implantable MEAs and FETs for complex multichannel neuronal communication – targeting the specificity in vivo of the implantable devices for 3 high-impact clinical applications.
|Neurocare partners will test interfaceable and implantable devices via in vitro and in vivo testing.|
federates 12 partners: CEA (LIST and CLINATEC), Ecole Supérieure d’Ingénieurs en Electronique, Forschungszentrum Jülich, Qwane Biosciences, University College London (London Centre for Nanotechnology), University Medical Center of the Johannes Gutenberg University Mainz, Obelia, Nanoretina, University Pierre et Marie Curie, Technical University of Munich, CNRS and Kurt Salmon.